Guidewire having enlarged, micro-fabricated distal section

Information

  • Patent Grant
  • 12178975
  • Patent Number
    12,178,975
  • Date Filed
    Thursday, January 21, 2021
    3 years ago
  • Date Issued
    Tuesday, December 31, 2024
    3 days ago
Abstract
Disclosed is a guidewire having a core wire and an outer tube within which the distal section of the core is inserted. The outer diameter of the tube is greater than the outer diameter of the proximal section of the core wire. The guidewire also includes a proximal coil and a distal, radiopaque coil each disposed over the distal section of the core. A bushing coil is disposed over the proximal coil and distal coil. The proximal coil, distal coil, and bushing coil aid in filling the annular space between the core and the tube and thereby centering and aligning the core and tube.
Description
BACKGROUND

Guidewire devices are often used to lead or guide catheters or other interventional devices to a targeted anatomical location within a patient's body. Typically, guidewires are passed into and through a patient's vasculature in order to reach the target location, which may be at or near the patient's heart or brain, for example. Radiographic imaging is typically utilized to assist in navigating a guidewire to the targeted location. In many instances, a guidewire is placed within the body during the interventional procedure where it can be used to guide multiple catheters or other interventional devices to the targeted anatomical location.


Guidewires are available with various outer diameter sizes. Widely utilized sizes include 0.010, 0.014, 0.016, 0.018, 0.024, 0.035, and 0.038 inches, for example, though they may also be smaller or larger in diameter. Because torque transmission is a function of diameter, larger diameter guidewires typically have greater torque transmission (the ability to effectively transfer torque from proximal portions of the wire to more distal portions of the wire). On the other hand, smaller diameter guidewires typically have greater flexibility.


A catheter used in conjunction with a guidewire will be sized with an inner diameter somewhat larger than the outer diameter of the guidewire to enable the catheter to be positioned over and translated upon the guidewire. The difference in size between the guidewire and catheter can affect the ability of the catheter to travel along the guidewire. For example, the larger the annular space between the outer diameter of the guidewire and the inner diameter of the catheter, the greater the amount of potential radial offset the catheter may experience and the more difficult it may be to navigate the catheter over the guidewire. With excessive radial offset, the distal end of the catheter may have a higher risk of catching against vasculature or other anatomy of the patient rather than smoothly following along the guidewire path.


Often, a guidewire size is selected to minimize the amount of annular space between the guidewire and a given catheter size required or desired for a particular procedure, and to thereby limit the types of issues described above. However, several challenges exist to this approach. For example, increasing the size of the guidewire may overly increase the stiffness of the guidewire as well, potentially to levels that are undesirable for the initial placement of the guidewire at the targeted treatment site. Moreover, while there are known methods for increasing guidewire flexibility, such as reducing the core wire diameter, but these often come at the expense of torquability of the device.


What is needed, therefore, is a guidewire device capable of being manufactured with a relatively large outer diameter, at least at the distal section, that minimizes the annular space between the guidewire and certain sizes of compatible catheters, and that is also capable of providing sufficient flexibility and torquability along its length.





BRIEF DESCRIPTION OF THE DRAWINGS

Various objects, features, characteristics, and advantages of the invention will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings and the appended claims, all of which form a part of this specification. In the Drawings, like reference numerals may be utilized to designate corresponding or similar parts in the various Figures, and the various elements depicted are not necessarily drawn to scale, wherein:



FIG. 1 illustrates an embodiment of a guidewire device having a core and an outer tube and which may utilize one or more of the components described herein;



FIG. 2 illustrates an exemplary embodiment of a guidewire device with a tube that has an outer diameter that is larger than an outer diameter of a proximal section of the core;



FIG. 3 is a detailed view of the distal section of the guidewire of FIG. 2, with the tube structure removed to better illustrate underlying features of the device;



FIG. 4 is a detailed view of the tube of the guidewire of FIG. 2;



FIG. 5 is a cross-sectional view of a distal section of the guidewire of FIG. 2, showing alignment of the beams of a one-beam section of the tube with a flattened distal section of the core; and



FIGS. 6 and 7 are cross-sectional views of the guidewire of FIG. 2 showing that the outer diameter of the tube is greater than the outer diameter of the proximal section of the core.





DETAILED DESCRIPTION
Introduction


FIG. 1 schematically illustrates the general components of a guidewire 100 that may utilize one or more features described in greater detail below. The illustrated guidewire 100 includes a core 102 and an outer tube 104. The core 102 includes a distal section 103 (also referred to herein as the distal core 103) that extends into the outer tube 104 as shown. The distal core 103 may be tapered, either continuously or in one or more discrete sections, so that more distal sections have a smaller diameter and greater flexibility than more proximal sections. In some embodiments, the most distal section of the core 102 may be flattened into a ribbon-like shape with a flat, rectangular, or oblong cross section. For example, the distal core 103 may be ground so as to progressively taper to a smaller diameter at the distal end.


The core 102 and the tube 104 are typically formed from different materials. For example, the tube 104 is preferably formed from a relatively flexible and elastic material such as nitinol, whereas the core 102 may be formed from a relatively less flexible and elastic material such as stainless steel. Forming the core 102 from stainless steel (or other materials with similar modulus of elasticity) may be advantageous because it allows the distal tip to hold a shape when selectively bent/shaped by an operator and because stainless steel provides sufficient modulus of elasticity to provide more responsive translational movement. While these materials are presently preferred, other suitable materials such as polymers or other metals/alloys may additionally or alternatively be utilized.


The tube 104 is coupled to the core 102 (e.g., using adhesive, soldering, and/or welding) in a manner that beneficially allows torsional forces to be transmitted from the core 102 to the tube 104 and thereby to be further transmitted distally by the tube 104. A medical grade adhesive or other suitable material may be used to couple the tube 104 to the core wire 102 at the distal end 110 of the device to form an atraumatic covering.


The outer tube 104 may include a cut pattern that forms fenestrations 106 in the tube. The pattern of fenestrations 106 may be arranged to provide desired flexibility characteristics to the tube 104, including the promotion of preferred bending directions, the reduction or elimination of preferred bending directions, or gradient increases in flexibility along the longitudinal axis, for example. Examples of cut patterns and other guidewire device features that may be utilized in the guidewire devices described herein are provided in detail in United States Patent Application Publication Nos. 2018/0193607, 2018/0071496, and 2020/0121308, the entireties of each of which are incorporated herein by this reference.


The proximal section of the guidewire device 100 (the portion extending proximally from the tube 104) extends proximally to a length necessary to provide sufficient guidewire length for delivery to a targeted anatomical area. The guidewire device 100 typically has a length ranging from about 50 cm to about 350 cm, more commonly about 200 cm, depending on particular application needs. The tube 104 may have a length ranging from about 5 cm to about 350 cm, more typically about 15 cm to about 50 cm, such as about 25 cm to about 40 cm.


The guidewire device 100 may have a diameter of about 0.010 inches to about 0.038 inches, though larger or smaller sizes may also be utilized depending on particular application needs. For example, particular embodiments may have outer diameter sizes corresponding to standard guidewire sizes such as 0.014 inches, 0.016 inches, 0.018 inches, 0.024 inches, or other such sizes common to guidewire devices. The distal section 103 of the core 102 may taper to a diameter of about 0.002 inches, or a diameter within a range of about 0.001 to 0.005 inches. In some embodiments, the distal tip may be flattened (e.g., to a rectangular cross section) to further enhance bending flexibility while minimizing reductions in cross-sectional area needed for tensile strength. In such embodiments, the cross section may have dimensions of about 0.001 inches by 0.003 inches, for example. In some embodiments, the tube 104 has a length within a range of about 3 to 350 cm.


Additional features and details regarding the foregoing components are described in further detail below. The following examples may be particularly beneficial in applications where the corresponding catheter is about sized at 0.027 inches or greater, and the guidewire is thus beneficially sized at about 0.024 inches or greater in order to limit the amount of annular space between the inner surface of the catheter and the outer surface of the guidewire, but still allow for relative movement between them. In such implementations, the guidewires described herein are able to provide sufficient diameter in the distal sections of the device to limit the annular space, while still maintaining effective torqueability and lateral flexibility. These sizes are not limiting, however, and the same features and details described below may also be utilized in guidewires that are smaller or larger than 0.024 inches.


Improved Guidewire Device with Enlarged Distal Section



FIG. 2 illustrates an example of a guidewire 200. Except where noted herein, the guidewire 200 may include any of the general features described above in relation to guidewire 100, with like reference numbers indicating like parts. As shown, the guidewire 200 includes a core 202 and an outer tube 204, with a distal section 203 of the core 202 inserted into the tube 204. The outer tube 204 includes a plurality of fenestrations 206. A polymer-based adhesive may form an atraumatic distal tip 210.


The core 202 also includes a proximal section 201 (also referred to herein as the proximal core 201) that is disposed proximal of the outer tube 204 and is not inserted into the outer tube 204. The proximal core 201 may comprise a friction-lowering coating, such as polytetrafluoroethylene (PTFE) and/or other suitable coating materials. The tube 204 may also include a coating, preferably a suitable hydrophilic coating and/or other suitable coating materials.


Preferably, the outer diameter of the tube 204 is slightly larger than the outer diameter of the proximal core 201. In one exemplary embodiment, the proximal core 201 has an outer diameter of about 0.018 inches, while the tube 204 has an outer diameter of about 0.024 inches. Other core and/or tube sizes may also be utilized, however. Preferably, the tube 204 has an outer diameter that is about 10% or more larger than the outer diameter of the proximal core 201, more preferably about 15% to about 80% larger, or more preferably about 20% to about 70% larger, such as about 25% to about 35% larger.


This is further illustrated by the cross-sectional views of FIGS. 6 and 7. As shown, the outer diameter (D1) of the proximal core 201 is less than the outer diameter (D2) of the tube 204. The ratio of D2 to D1 may be, for example, about 1.1 to about 3, more preferably about 1.15 to about 2, or about 1.2 to about 1.75.


As mentioned above, a larger outer diameter in the tube 204 can better match certain desired catheter sizes at the catheter distal tip portion and thereby reduce the amount of annular space between the guidewire and catheter during placement of the catheter over the guidewire. This is particularly beneficial at the more distal sections of the guidewire, which are more likely to be navigated through deeper, more tortuous portions of the patient's vasculature.


However, increasing the diameter of the core 202 to match the larger diameter of the tube 204 may make the core 202 too stiff for use in certain desired applications. Thus, maintaining a smaller core 202, while increasing the size of the tube 204 relative to the core 202, allows use of the more flexible core 202 while still enabling the benefits of a larger tube 204 at the distal sections of the guidewire 200.


As explained in more detail below, however, providing a tube 204 that has a larger outer diameter than the core 202 can introduce other challenges. In particular, the difference in diameter between the outer tube 204 and the distal core 203 enlarges the annular space between the outer surface of the distal core 203 and the inner surface of the tube 204. Because the tube 204 can be more flexible than the distal core 203, as the wire navigates a bend, the distal core 203 may be positioned off-center from the center line of the tube 204. As the guidewire is moved through the vasculature, this off-centering can disrupt the smooth distal transmission of rotational movement, causing a buildup and sudden release of forces which lead the guidewire to move with a “snap” and/or “whip” to a non-desired preferential rotational location. This disruption to the tactile feel and rotational control of the guidewire can make it more difficult for the operator to rotationally position the guidewire as intended, raising the risk of interventional procedure delays, suboptimal outcomes, inability to access the target location, or even tissue injury.


The embodiments described herein beneficially provide additional features that assist in radially centering the distal core 203 within the tube 204 even though the tube 204 has a larger outer diameter than the proximal core 201. One or more centering mechanisms may be included to beneficially reduce undesirable whip and/or snap movements of the guidewire (i.e., the centering mechanisms may improve rotational control), thereby enabling a user to have greater rotational control and improved tactile handling of the guidewire.



FIG. 3 illustrates an expanded view of the distal section of the guidewire 200 with the tube 204 removed in order to better visualize the distal core 203 and some of the other underlying components. As shown, the core 202 includes one or more transition zones 208 where the core 202 tapers to a smaller diameter. A distal end section 211 of the core 202 may be flattened. The one or more transition zones 208 may be discrete, with one or more sections of the core of substantially continuous outer diameter disposed between, or the distal core 203 may have a substantially continuous taper along all or most of its length.


A bushing 212 may be included at the point forming the joint to which the proximal end of the tube 204 is attached. The bushing 212 may have an outer diameter that substantially matches the outer diameter of the proximal core 201. The bushing 212 may be formed from the same material as the tube 204 (e.g., nitinol). The bushing 212 provides for better centering between the core 202 and the tube 204 and/or reduces the amount of adhesive needed to bond the separate components. Although shown here as a tube, the bushing 212 may have alternative geometries such as a coil, braid, slotted/cut tube, etcetera.


As shown, the bushing 212 may also include a chamfered or beveled surface 214 on its proximal end to provide a smooth transition between different diameters. The distal end of the bushing 212 may also be chamfered or beveled. Even though the distal end of the bushing 212 will be covered by the tube 204, providing a bushing 212 with a chamfer/bevel on both ends can aid in manufacturing, eliminating the need to ensure proper orientation of the bushing and eliminating the potential for erroneous orientation.


The illustrated guidewire 200 includes a proximal coil 216, a distal coil 218, and a bushing coil 220 positioned over the proximal coil 216 and the distal coil 218. The distal coil 218 is preferably formed of a radiopaque material, such as platinum group, gold, silver, palladium, iridium, osmium, tantalum, tungsten, bismuth, dysprosium, gadolinium, and the like. The distal coil 218 thus preferably allows radiographic visualization of the distal end of the guidewire 200 during a procedure. The distal coil 218 may have a length of about 0.5 cm to about 20 cm, or more typically about 3 cm to about 15 cm, such as about 10 cm.


The proximal coil 216 may be formed from a non-radiopaque material such as stainless steel, other suitable metal, a suitable polymer, or other suitable material. The proximal coil 216 may be attached to the distal core 203 at a point adjacent to or near to the proximal end of the distal coil 218 and/or at any point along the coincident length of the distal core 203, most commonly at or near each end of the proximal coil 216. The proximal coil 216 may have a length of about 1 to 25 cm, or more typically about 3 to 20 cm, such as about 5 to 15 cm. Technically, the distal coil 218 could be extended further proximally to take the place of the proximal coil 216. However, materials that function well as radiopaque markers (e.g., platinum) are relatively expensive. Also, their use as a packing material to fill large portions of the annular space could cause the distal section of the guidewire 200 to be overly bright when imaged under x-ray fluoroscopy and thus not allow the operator to visualize other areas of interest. Thus, the proximal coil 216 is preferably separate from, and formed from a different material than, the distal coil 218.


The proximal coil 216 and the distal coil 218 aid in filling some of the annular space between the distal core 203 and the tube 204. Although the coil examples illustrated herein are shown having wires with a circular cross section, it will be understood that other coil types may also be utilized. For example, centering coil(s) may be edge-wound and/or may have a ribbon, rectangular, oblong, or other non-circular shaped cross-sectional shape.


Although the proximal coil 216 and distal coil 218 aid in filling some of the annular space, additional annular space remains, particularly when a somewhat larger tube 204 is utilized. The wire size of the proximal coil 216 and distal coil 218 could be increased to fill more space. However, increasing wire size too much may introduce excessive stiffness to the device. Preferably, the wire size of the proximal coil 216 and distal coil 218 is about 0.008 inches or less, or about 0.006 inches or less, or more preferably about 0.004 inches or less, such as about 0.002 inches or less.


To aid in filling the remainder of the annular space, the guidewire 200 may include a bushing coil 220. The bushing coil 220 may be disposed over the proximal coil 216 and the distal coil 218. The bushing coil 220 may extend over the entirety of both of the proximal coil 216 and the distal coil 218. As with the proximal coil 216 and the distal coil 218, the wire diameter of the bushing coil 220 is preferably limited. For example, the wire diameter of the bushing coil may be about 0.008 inches or less, or about 0.006 inches or less, or more preferably about 0.004 inches or less, such as about 0.002 inches or less. The bushing coil 220 may be formed of stainless steel and/or other suitable material, such as another metal or a polymer.


The use of a bushing coil 220 in addition to the proximal coil 216 and distal coil 218 aids in filling the annular space between the distal core 203 and the tube 204 without the use of over-sized coils. This aids in maintaining centering of the distal core 203 within the tube 204, which prevents the undesirable effects of misalignment that have been described above while also minimally impacting the bending flexibility of the device.


In some embodiments, the bushing coil 220 may be substantially coincident with the proximal coil 216 and the distal coil 218. Alternatively, as shown, the bushing coil 220 may extend farther proximally than the proximal coil 216. This allows the bushing coil 220 to fill in more of the annular space even at portions where the proximal coil 216 is not able. That is, because of the tapered profile of the distal core 203, certain more proximal portions of the annular space do not fit both the proximal coil 216 and the bushing coil 220, but may still be filled by the further extending proximal portion of the bushing coil 220. The bushing coil 220 preferably extends along a substantial portion of the length of the tube 204. For example, the bushing coil 220 may have a length of at least about 60% of the length of the tube 204, or at least about 75% of the length of the tube 204, or at least about 80% of the length of the tube 204, or at least about 85% of the length of the tube 204.


In preferred embodiments, the proximal coil 216 and the distal coil 218 are each wound in a first direction, while the bushing coil 220 is counter-wound in a second, opposite direction. This beneficially limits interlocking and binding of the bushing coil 220 to either of the proximal coil 216 or the distal coil 218. The bushing coil 220 may also have a pitch that is different (e.g., narrower) than that of the proximal coil 216 or the distal coil 218. For example, the proximal coil 216 and/or the distal coil 218 may have a pitch of about 0.002 inches to about 0.008 inches, or about 0.003 inches to about 0.007 inches, whereas the bushing coil 220 may have a pitch of about 0.001 inches to about 0.006 inches, or about 0.002 inches to about 0.005 inches.


The proximal coil 216, the distal coil 218, and the bushing coil 220 are preferably configured to fill a substantial portion of the volume of the annular space between the distal core 203 and the tube 204. For example, proximal coil 216, the distal coil 218, and the bushing coil 220 may be configured to fill approximately 20% or more, 35% or more, 50% or more, 60% or more, 70% or more, 80% or more, or even up to about 90% or more of the volume of the annular space. Of course, other conventional guidewires may include joints or bushings that fill up large portions of the annular space at the particular part of the guidewire they are located. However, when the entire length of the outer tube is considered, such joints and bushings fill relatively little of the volume of the overall annular space.


The centering mechanism principles described herein may be utilized with other structural configurations to provide beneficial centering effects. For example, while the above embodiments describe various centering mechanisms with a core as the “inner member” and a microfabricated tube as the “outer member,” other structures may additionally or alternatively be utilized as the outer and/or inner members along with one or more of the described centering mechanisms.


For example, the inner member may be a wire (such as a ground core as described above), a tube (e.g., metal or polymer hypotube or metal or polymer microfabricated tube), a braid, or a coil. By way of further example, the outer member may be a tube (e.g., metal or polymer hypotube or metal or polymer microfabricated tube), a braid, a coil, or a polymer tube impregnated with a braid or coil. The centering mechanism may include a set of coils such as those described above, or may additionally or alternatively include other structures for providing centering of the inner member within the outer member. For example, one or more of the coils 216, 218, 220 may be replaced by one or more tubes (e.g., metal or polymer hypotube or metal or polymer microfabricated tube), braided sections, or sets of stacked rings.



FIG. 4 illustrates the tube 204 separate from the core 202 and some of the other components of the device. The tube 204 extends between a proximal end 222 and a distal end 224. The fenestrations 206 formed within the tube 204 may be made according to a variety of cut patterns. Preferably, the overall effect of the fenestrations provides a flexibility gradient across the tube 204 where more flexibility increases closer to the distal end 224. Typically, greater flexibility can be provided by removing more of the stock material, such as by increasing the depth of the cut, decreasing the space between adjacent cuts, and/or reducing the number of axially extending beams 226 connecting each of the circumferentially extending rings 228.


The illustrated embodiment, for example, may include a three-beam section 230 (three beams connecting each adjacent pair of rings) that transitions to a two-beam section 232 (two beams connecting each adjacent pair of rings) that transitions to a one-beam section 234 (a single beam connecting each adjacent pair of rings). Within each of these sections, the cut depth and/or cut spacing may also be adjusted to provide a smooth intra-section and inter-section flexibility gradient. For example, the two-beam section 232 may have progressively less distance between cuts as it advances toward the distal end 224. It may then transition to the one-beam section 234, which itself then includes progressively less distance between cuts as it advances toward the distal end 224.


The one-beam section 234 may have a length of about 0.5 cm to about 3 cm, or about 0.75 cm to about 2 cm, for example. The two-beam section 232 may have a length of about 4 cm to about 16 cm, or about 6 cm to about 12 cm, for example. The three-beam section 230 may have a length of about 12 cm to about 36 cm, or about 18 cm to about 30 cm, for example. In other words, the three-beam section 230 may be about 2 to 5 times longer than the two-beam section 232, and the two-beam section 232 may be about 2 to 5 times longer than the one-beam section 234. Designing the tube 204 with these proportions of cut/beam sections has been found to provide effective balance of axial, lateral, and torsional stiffness for most applications.


The tube 204 may also include a distal-most section 235 that has a two-beam pattern. This section is preferably relatively short, such as about 0.5 cm or less, or about 0.25 cm or less, or about 0.15 cm or less. Providing a relatively short two-beam section at section 235 provides added surface area for an adhesive material applied at or near the distal end 224 of the tube 204 to bond, allowing a stronger coupling between the distal end 224 and any internal components bonded thereto.


Certain sections of the tube 204 may have cuts that are rotationally offset so as to avoid the formation of any preferred bending planes. For example, an angular offset may be applied after each cut or series of cuts such that the overall resulting pattern of beams 226 in the tube 204 do not align in a way that forms preferred bending planes.


Other sections of the tube 204 may include a preferred bending plane. For example, the one-beam section 234 may be aligned as shown in FIG. 4, with each beam offset by about 180° from the previous beam. These beams may also be aligned with the bending plane of the flattened distal end section 211 of the core. FIG. 5 illustrates, in cross-section, how the beams 226 of the one-beam section 234 are preferably aligned in the same plane as the flattened, wider section of the distal end section 211 of the core.


CONCLUSION

While certain embodiments of the present disclosure have been described in detail, with reference to specific configurations, parameters, components, elements, etcetera, the descriptions are illustrative and are not to be construed as limiting the scope of the claimed invention.


Furthermore, it should be understood that for any given element of component of a described embodiment, any of the possible alternatives listed for that element or component may generally be used individually or in combination with one another, unless implicitly or explicitly stated otherwise.


In addition, unless otherwise indicated, numbers expressing quantities, constituents, distances, or other measurements used in the specification and claims are to be understood as optionally being modified by the term “about” or its synonyms. When the terms “about,” “approximately,” “substantially,” or the like are used in conjunction with a stated amount, value, or condition, it may be taken to mean an amount, value or condition that deviates by less than 20%, less than 10%, less than 5%, or less than 1% of the stated amount, value, or condition. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.


Any headings and subheadings used herein are for organizational purposes only and are not meant to be used to limit the scope of the description or the claims.


It will also be noted that, as used in this specification and the appended claims, the singular forms “a,” “an” and “the” do not exclude plural referents unless the context clearly dictates otherwise. Thus, for example, an embodiment referencing a singular referent (e.g., “widget”) may also include two or more such referents.


It will also be appreciated that embodiments described herein may include properties, features (e.g., ingredients, components, members, elements, parts, and/or portions) described in other embodiments described herein. Accordingly, the various features of a given embodiment can be combined with and/or incorporated into other embodiments of the present disclosure. Thus, disclosure of certain features relative to a specific embodiment of the present disclosure should not be construed as limiting application or inclusion of said features to the specific embodiment. Rather, it will be appreciated that other embodiments can also include such features.

Claims
  • 1. An intravascular device, comprising: a core having a proximal section and a distal section;an outer tube coupled to the core such that the distal section of the core passes into and is encompassed by the outer tube, the outer tube and the core defining an annular space between an inner surface of the outer tube and the distal section of the core disposed within the outer tube;a distal coil encompassing part of the distal section of the core;a proximal coil disposed proximal of the distal coil and encompassing part of the distal section of the core; anda bushing coil disposed over at least a portion of the distal coil and over at least a portion of the proximal coil,wherein the distal coil, proximal coil, and bushing coil fill at least a portion of the annular space,wherein an outer diameter of the outer tube is greater than an outer diameter of the proximal section of the core, andwherein the outer tube includes fenestrations that form a plurality of axially extending beams connecting circumferentially extending rings, wherein the fenestrations form a two-beam section proximal of a one-beam section proximal of a distal-most two-beam section.
  • 2. The device of claim 1, wherein the distal coil is more radiopaque than stainless steel.
  • 3. The device of claim 1, wherein the proximal coil is less radiopaque than the distal coil.
  • 4. The device of claim 1, wherein a wire size of the distal coil, proximal coil, and/or bushing coil is about 0.006 inches or less.
  • 5. The device of claim 1, wherein the bushing coil extends farther proximally than the proximal coil.
  • 6. The device of claim 1, wherein the bushing coil has a length of at least about 60% of the length of the outer tube.
  • 7. The device of claim 1, wherein at least one of the proximal coil, distal coil, and bushing coil is wound in a direction opposite the other coils.
  • 8. The device of claim 7, wherein the proximal coil and the distal coil are each wound in a first direction, while the bushing coil is counter-wound in a second, opposite direction.
  • 9. The device of claim 1, wherein the bushing coil has a pitch that is smaller than that of the proximal coil and/or distal coil.
  • 10. The device of claim 1, wherein the proximal coil, distal coil, and bushing coil fill 50% or more of the volume of the annular space.
  • 11. The device of claim 1, wherein the outer diameter of the outer tube is larger than the outer diameter of the proximal section of the core by 15% to 80%.
  • 12. The device of claim 1, further comprising a bushing disposed at a proximal end of the outer tube to aid in coupling the outer tube to the core.
  • 13. The device of claim 12, wherein the bushing comprises a chamfered or beveled proximal edge.
  • 14. The device of claim 13, wherein the bushing also comprises a chamfered or beveled distal edge.
  • 15. The device of claim 1, wherein the outer tube includes at least one of a three-beam section, a two-beam section, and a one-beam section.
  • 16. The device of claim 1, wherein a flattened distal section of the core has a preferred bending plane and wherein the preferred bending plane of the flattened distal section is aligned with a preferred bending plane of a portion of the outer tube overlying the flattened distal section.
  • 17. The device of claim 1, wherein the distal-most two-beam section is shorter than the one-beam section.
  • 18. An intravascular device, comprising: a core having a proximal section and a distal section;an outer tube coupled to the core such that the distal section of the core passes into and is encompassed by the outer tube, the outer tube and the core defining an annular space between an inner surface of the outer tube and the distal section of the core disposed within the outer tube, wherein an outer diameter of the outer tube is greater than an outer diameter of the proximal section of the core;a distal coil encompassing part of the distal section of the core;a proximal coil disposed proximal of the distal coil and encompassing part of the distal section of the core;a bushing coil disposed over the distal coil and the proximal coil; anda bushing disposed at a proximal end of the outer tube to aid in coupling the outer tube to the core,wherein the bushing comprises a chamfered or beveled proximal edge and a chamfered or beveled distal edge.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 62/965,005, filed Jan. 23, 2020 and titled “Guidewire Having Enlarged, Micro-Fabricated Distal Section”, the entirety of which is incorporated herein by reference.

US Referenced Citations (489)
Number Name Date Kind
2022065 Wappler Nov 1935 A
2187299 Otto Jan 1940 A
3183702 Zittell May 1965 A
3572334 Petterson Mar 1971 A
3612058 Ackerman Oct 1971 A
3709271 Flory Jan 1973 A
3782233 Helm Jan 1974 A
3920058 Walker Nov 1975 A
4163406 Crawford Aug 1979 A
4239069 Zimmerman Dec 1980 A
4416312 Destberg Nov 1983 A
4688540 Ono Aug 1987 A
4719924 Crittenden et al. Jan 1988 A
4801297 Mueller Jan 1989 A
4846186 Box et al. Jul 1989 A
4895168 Machek Jan 1990 A
4989608 Ratner Feb 1991 A
5047045 Arney et al. Sep 1991 A
5069217 Fleischhacker, Jr. Dec 1991 A
5084022 Claude Jan 1992 A
5095915 Engelson Mar 1992 A
5102390 Crittenden et al. Apr 1992 A
5144959 Gambale et al. Sep 1992 A
5147317 Shank et al. Sep 1992 A
5154725 Leopold Oct 1992 A
5174302 Palmer Dec 1992 A
5315996 Lundquist May 1994 A
5326374 Ilbawi et al. Jul 1994 A
5345945 Hodgson et al. Sep 1994 A
5372587 Hammerslag et al. Dec 1994 A
5381782 Delarama et al. Jan 1995 A
5382259 Phelps et al. Jan 1995 A
5385152 Abele et al. Jan 1995 A
5437288 Schwartz et al. Aug 1995 A
5441483 Avitall Aug 1995 A
D363544 Rowland et al. Oct 1995 S
D363776 Rowland et al. Oct 1995 S
5506682 Pryor Apr 1996 A
5507751 Goode et al. Apr 1996 A
5551444 Finlayson Sep 1996 A
5554114 Wallace et al. Sep 1996 A
5569218 Berg Oct 1996 A
5573520 Schwartz et al. Nov 1996 A
5573867 Zafred et al. Nov 1996 A
5606981 Tartacower et al. Mar 1997 A
5659205 Weisser Aug 1997 A
5673707 Chandrasekaran Oct 1997 A
5676659 McGurk Oct 1997 A
5685568 Pirrello Nov 1997 A
5685868 Lundquist Nov 1997 A
5690120 Jacobsen et al. Nov 1997 A
5706826 Schwager Jan 1998 A
5741429 Donadio et al. Apr 1998 A
5746701 Noone May 1998 A
5792154 Doan et al. Aug 1998 A
5797857 Obitsu Aug 1998 A
5800454 Jacobsen et al. Sep 1998 A
5833631 Nguyen Nov 1998 A
5833632 Jacobsen et al. Nov 1998 A
5842461 Azuma Dec 1998 A
5860963 Azam et al. Jan 1999 A
5876356 Viera et al. Mar 1999 A
5911715 Berg et al. Jun 1999 A
5911717 Jacobsen et al. Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5931830 Jacobsen et al. Aug 1999 A
5954672 Schwager Sep 1999 A
6004279 Crowley et al. Dec 1999 A
6014919 Jacobsen Jan 2000 A
6017319 Jacobsen et al. Jan 2000 A
6022343 Johnson et al. Feb 2000 A
6022369 Jacobsen et al. Feb 2000 A
6027863 Donadio, III Feb 2000 A
6033288 Weisshaus et al. Mar 2000 A
6033394 Vidlund et al. Mar 2000 A
6056702 Lorenzo May 2000 A
6063101 Jacobsen et al. May 2000 A
6110164 Vidlund Aug 2000 A
6132389 Cornish et al. Oct 2000 A
6139511 Huter et al. Oct 2000 A
D435909 Ogino et al. Jan 2001 S
6168570 Ferrera Jan 2001 B1
6179828 Mottola et al. Jan 2001 B1
6183410 Jacobsen et al. Feb 2001 B1
6183420 Douk et al. Feb 2001 B1
6214042 Jacobsen et al. Apr 2001 B1
6228073 Noone et al. May 2001 B1
6245030 Dubois et al. Jun 2001 B1
6251086 Cornelius et al. Jun 2001 B1
6260458 Jacobsen et al. Jul 2001 B1
6261246 Pantages et al. Jul 2001 B1
6273881 Kiemeneij Aug 2001 B1
6302870 Jacobsen et al. Oct 2001 B1
6306105 Rooney et al. Oct 2001 B1
6346091 Jacobsen et al. Feb 2002 B1
6356791 Westlund et al. Mar 2002 B1
6402706 Richardson et al. Jun 2002 B2
6428489 Jacobsen et al. Aug 2002 B1
6431039 Jacobsen et al. Aug 2002 B1
6436056 Wang et al. Aug 2002 B1
6440088 Jacobsen et al. Aug 2002 B1
6458867 Wang et al. Oct 2002 B1
6464651 Hiejima et al. Oct 2002 B1
6492615 Flanagan Dec 2002 B1
6494894 Mirarchi Dec 2002 B2
6527732 Strauss et al. Mar 2003 B1
6527746 Oslund et al. Mar 2003 B1
6553880 Jacobsen et al. Apr 2003 B2
6554820 Wendlandt et al. Apr 2003 B1
6558355 Metzger et al. May 2003 B1
6579246 Jacobsen et al. Jun 2003 B2
6602207 Mam et al. Aug 2003 B1
6606985 Negishi Aug 2003 B2
6610046 Usami et al. Aug 2003 B1
6627724 Meijs et al. Sep 2003 B2
6652508 Griffin et al. Nov 2003 B2
6671560 Westlund et al. Dec 2003 B2
6766720 Jacobsen et al. Jul 2004 B1
6805676 Klint Oct 2004 B2
6866642 Kellerman et al. Mar 2005 B2
RE39018 Azuma et al. Mar 2006 E
7024885 Villalobos Apr 2006 B2
7097624 Campion et al. Aug 2006 B2
7110910 Deffenbaugh et al. Sep 2006 B1
7128718 Hojeibane et al. Oct 2006 B2
7172587 Poole et al. Feb 2007 B2
7182735 Shireman et al. Feb 2007 B2
7276062 McDaniel et al. Oct 2007 B2
7338345 Fujinami Mar 2008 B2
7421929 French Sep 2008 B2
7494474 Richardson et al. Feb 2009 B2
7507246 McGuckin et al. Mar 2009 B2
D598094 Alber Aug 2009 S
7621880 Ryan et al. Nov 2009 B2
7637875 Itou Dec 2009 B2
7641622 Satou et al. Jan 2010 B2
D611596 Kousai et al. Mar 2010 S
7670302 Griffin et al. Mar 2010 B2
7699792 Hofmann et al. Apr 2010 B2
7722545 Bertsch May 2010 B2
7722552 Aimi et al. May 2010 B2
7744545 Aimi et al. Jun 2010 B2
7747314 Parins et al. Jun 2010 B2
7753859 Kinoshita et al. Jul 2010 B2
7766896 Kornkven et al. Aug 2010 B2
7769839 Boivie et al. Aug 2010 B2
7785273 Eskuri Aug 2010 B2
7789839 Lupton Sep 2010 B2
7806837 Rasmussen et al. Oct 2010 B2
7878984 Jacobsen et al. Feb 2011 B2
7883474 Mirigian et al. Feb 2011 B1
7914467 Ayman et al. Mar 2011 B2
7942832 Kanuka et al. May 2011 B2
7989042 Obara et al. Aug 2011 B2
8007434 Olson Aug 2011 B2
8043314 Noriega et al. Oct 2011 B2
8048004 Davis et al. Nov 2011 B2
8092444 Lentz et al. Jan 2012 B2
8105246 Voeller et al. Jan 2012 B2
8128579 Chen et al. Mar 2012 B2
8128580 Fujimagari et al. Mar 2012 B2
8137293 Zhou et al. Mar 2012 B2
8167821 Sharrow May 2012 B2
8257279 Jacobsen Sep 2012 B2
8292827 Musbach et al. Oct 2012 B2
8292828 Bernhard Oct 2012 B2
8357140 Majercak et al. Jan 2013 B2
8376865 Forster et al. Feb 2013 B2
8376961 Layman et al. Feb 2013 B2
8377056 Oyola et al. Feb 2013 B2
8409114 Parins Apr 2013 B2
8409169 Moss Apr 2013 B1
8444577 Bunch et al. May 2013 B2
8454535 Majercak et al. Jun 2013 B2
8460213 Northrop Jun 2013 B2
8465469 Brightbill Jun 2013 B2
8468919 Christian et al. Jun 2013 B2
8500658 Boyle et al. Aug 2013 B2
8517959 Kurosawa et al. Aug 2013 B2
8535243 Shireman Sep 2013 B2
8540648 Bernhard Sep 2013 B2
8540668 Griffin et al. Sep 2013 B2
8551020 Chen et al. Oct 2013 B2
8551021 Voeller et al. Oct 2013 B2
8556914 Vrba Oct 2013 B2
8585643 Vo et al. Nov 2013 B2
8622931 Teague et al. Jan 2014 B2
8622933 Maki et al. Jan 2014 B2
8728075 Wu et al. May 2014 B2
8758269 Miyata et al. Jun 2014 B2
8784337 Voeller et al. Jul 2014 B2
8795202 Northrop et al. Aug 2014 B2
8795254 Layman et al. Aug 2014 B2
8821477 Northrop et al. Sep 2014 B2
8870790 Davis et al. Oct 2014 B2
8900163 Jacobsen et al. Dec 2014 B2
8915865 Jacobsen et al. Dec 2014 B2
8932235 Jacobsen et al. Jan 2015 B2
8936558 Jacobsen et al. Jan 2015 B2
8939916 Jacobsen et al. Jan 2015 B2
8956310 Miyata et al. Feb 2015 B2
9011511 Gregorich et al. Apr 2015 B2
9067332 Lippert et al. Jun 2015 B2
9067333 Lippert et al. Jun 2015 B2
9072873 Lippert et al. Jul 2015 B2
9072874 Northrop et al. Jul 2015 B2
D742000 Kanazawa Oct 2015 S
9162040 Vo et al. Oct 2015 B2
9227037 Northrop Jan 2016 B2
9364589 Cage et al. Jun 2016 B2
9375234 Vrba Jun 2016 B2
9433762 Griffin et al. Sep 2016 B2
9439557 Boulais Sep 2016 B2
9550013 Kawasaki Jan 2017 B2
9616195 Lippert et al. Apr 2017 B2
9623212 Tano et al. Apr 2017 B2
9662798 Christian et al. May 2017 B2
9700702 Tano et al. Jul 2017 B2
9808595 Turnlund et al. Nov 2017 B2
9839764 Chouinard Dec 2017 B2
9848882 Lippert Dec 2017 B2
D809138 Khan et al. Jan 2018 S
9950137 Lippert et al. Apr 2018 B2
9999748 Cajamarca et al. Jun 2018 B2
10028666 Gregorich Jul 2018 B2
10052013 Boulais Aug 2018 B2
10149608 Fujitani Dec 2018 B2
D839426 Bajwa Jan 2019 S
D847335 Kuwada Apr 2019 S
10252024 Northrop Apr 2019 B2
D855180 Haefliger Jul 2019 S
10350383 Shuman Jul 2019 B2
10363389 Lippert et al. Jul 2019 B2
D855800 Gabay et al. Aug 2019 S
10420537 Salahieh et al. Sep 2019 B2
10456556 Cabiri Oct 2019 B2
10639456 Peralta May 2020 B2
10675444 Kauphusman et al. Jun 2020 B2
10758710 Romano Sep 2020 B2
10806893 Jaroch Oct 2020 B2
11007345 Cottone May 2021 B2
11052226 Salahieh et al. Jul 2021 B2
11052228 Lippert Jul 2021 B2
11141566 Cabiri Oct 2021 B2
D946148 Takemoto Mar 2022 S
11278704 Pleijers Mar 2022 B2
11471645 McNiven et al. Oct 2022 B2
11497512 Wallace et al. Nov 2022 B2
11565093 Kirt et al. Jan 2023 B2
D980427 Method et al. Mar 2023 S
11679236 Von et al. Jun 2023 B2
11724065 Tilson et al. Aug 2023 B2
11724068 Von et al. Aug 2023 B2
11759217 Keating et al. Sep 2023 B2
11766539 Yee et al. Sep 2023 B2
D1014751 Shih Feb 2024 S
11918753 Moquin et al. Mar 2024 B2
11957312 Boulais Apr 2024 B2
20010009980 Richardson et al. Jul 2001 A1
20010044624 Seraj et al. Nov 2001 A1
20020013540 Jacobsen et al. Jan 2002 A1
20020019599 Rooney et al. Feb 2002 A1
20020049392 Demello Apr 2002 A1
20020062524 Vogland et al. May 2002 A1
20020068912 Merdan Jun 2002 A1
20020078808 Jacobsen et al. Jun 2002 A1
20020082524 Anderson et al. Jun 2002 A1
20030009208 Snyder et al. Jan 2003 A1
20030023190 Cox Jan 2003 A1
20030060732 Jacobsen et al. Mar 2003 A1
20030069521 Reynolds et al. Apr 2003 A1
20030069522 Jacobsen et al. Apr 2003 A1
20030093059 Griffin et al. May 2003 A1
20030125641 Jafari et al. Jul 2003 A1
20040039371 Tockman et al. Feb 2004 A1
20040054349 Brightbill Mar 2004 A1
20040087933 Lee et al. May 2004 A1
20040093060 Seguin et al. May 2004 A1
20040102719 Keith et al. May 2004 A1
20040102720 Kellerman et al. May 2004 A1
20040111044 Davis et al. Jun 2004 A1
20040122340 Vrba Jun 2004 A1
20040167437 Sharrow et al. Aug 2004 A1
20040167440 Sharrow Aug 2004 A1
20040167443 Shireman et al. Aug 2004 A1
20040171996 Kiemeneij Sep 2004 A1
20040181174 Davis et al. Sep 2004 A2
20040186485 Kear Sep 2004 A1
20040193140 Griffin et al. Sep 2004 A1
20040225292 Sasso et al. Nov 2004 A1
20040254450 Griffin et al. Dec 2004 A1
20050054953 Ryan et al. Mar 2005 A1
20050065456 Eskuri Mar 2005 A1
20050124976 Devens et al. Jun 2005 A1
20050137501 Euteneuer et al. Jun 2005 A1
20050216049 Jones et al. Sep 2005 A1
20050274384 Tran et al. Dec 2005 A1
20060006649 Galdonik et al. Jan 2006 A1
20060041186 Vancaillie Feb 2006 A1
20060074442 Noriega et al. Apr 2006 A1
20060089618 McFerran et al. Apr 2006 A1
20060112802 Fujinami Jun 2006 A1
20060121218 Obara et al. Jun 2006 A1
20060189896 Davis et al. Aug 2006 A1
20060241519 Hojeibane et al. Oct 2006 A1
20060247661 Richards et al. Nov 2006 A1
20060262474 Chen et al. Nov 2006 A1
20070010786 Casey et al. Jan 2007 A1
20070055302 Henry et al. Mar 2007 A1
20070100285 Griffin et al. May 2007 A1
20070112331 Weber et al. May 2007 A1
20070135763 Musbach et al. Jun 2007 A1
20070142893 Buiser et al. Jun 2007 A1
20070167876 Euteneuer et al. Jul 2007 A1
20070185415 Ressemann et al. Aug 2007 A1
20070221230 Thompson et al. Sep 2007 A1
20070233039 Mitelberg Oct 2007 A1
20070250036 Volk et al. Oct 2007 A1
20070282270 Mathews et al. Dec 2007 A1
20070287955 Layman et al. Dec 2007 A1
20080021347 Jacobsen et al. Jan 2008 A1
20080021401 Jacobsen Jan 2008 A1
20080021404 Jacobsen et al. Jan 2008 A1
20080021406 Jacobsen et al. Jan 2008 A1
20080064989 Chen et al. Mar 2008 A1
20080077049 Hirshman Mar 2008 A1
20080086854 Boyd et al. Apr 2008 A1
20080097246 Stafford Apr 2008 A1
20080097247 Eskuri Apr 2008 A1
20080097248 Munoz et al. Apr 2008 A1
20080114303 Tremaglio May 2008 A1
20080119869 Teague et al. May 2008 A1
20080122226 Madison May 2008 A1
20080125674 Bilecen et al. May 2008 A1
20080147170 Vrba Jun 2008 A1
20080188298 Seelig et al. Aug 2008 A1
20080188928 Salahieh et al. Aug 2008 A1
20080200839 Bunch et al. Aug 2008 A1
20080262474 Northrop Oct 2008 A1
20080269641 O'Shaughnessy et al. Oct 2008 A1
20080319525 Tieu et al. Dec 2008 A1
20090036832 Skujins et al. Feb 2009 A1
20090036833 Parins Feb 2009 A1
20090043283 Turnlund et al. Feb 2009 A1
20090043372 Northrop et al. Feb 2009 A1
20090118675 Czyscon et al. May 2009 A1
20090118704 Sharrow et al. May 2009 A1
20090177119 Heidner et al. Jul 2009 A1
20090177185 Northrop Jul 2009 A1
20090254000 Layman Oct 2009 A1
20090292225 Chen et al. Nov 2009 A1
20090318892 Aboytes et al. Dec 2009 A1
20100063479 Merdan et al. Mar 2010 A1
20100069882 Jennings Mar 2010 A1
20100114017 Lenker et al. May 2010 A1
20100114302 Tzafriri et al. May 2010 A1
20100139465 Christian et al. Jun 2010 A1
20100145308 Layman et al. Jun 2010 A1
20100228150 Zimmerman et al. Sep 2010 A1
20100256527 Lippert et al. Oct 2010 A1
20100256528 Lippert et al. Oct 2010 A1
20100256601 Lippert et al. Oct 2010 A1
20100256602 Lippert et al. Oct 2010 A1
20100256603 Lippert et al. Oct 2010 A1
20100256604 Lippert et al. Oct 2010 A1
20100256605 Lippert et al. Oct 2010 A1
20100256606 Lippert et al. Oct 2010 A1
20100318066 Miyata et al. Dec 2010 A1
20110011226 Tsurusawa et al. Jan 2011 A1
20110022003 Tekulve Jan 2011 A1
20110160680 Cage et al. Jun 2011 A1
20110245807 Sakata et al. Oct 2011 A1
20110245808 Voeller et al. Oct 2011 A1
20110251519 Romoscanu Oct 2011 A1
20110313417 De et al. Dec 2011 A1
20120046575 Brown Feb 2012 A1
20120065623 Nelson et al. Mar 2012 A1
20120158034 Wilson et al. Jun 2012 A1
20120209073 McWeeney et al. Aug 2012 A1
20120239074 Aboytes et al. Sep 2012 A1
20120271397 Muzslay et al. Oct 2012 A1
20120289938 Northrop et al. Nov 2012 A1
20130018280 Tano et al. Jan 2013 A1
20130018359 Coyle Jan 2013 A1
20130096553 Hill et al. Apr 2013 A1
20130110000 Tully et al. May 2013 A1
20130131642 Miyata et al. May 2013 A1
20130144267 Chan et al. Jun 2013 A1
20130184703 Shireman et al. Jul 2013 A1
20130226033 Eskuri Aug 2013 A1
20130255456 Christian et al. Oct 2013 A1
20140012281 Wang et al. Jan 2014 A1
20140031719 Kanazawa Jan 2014 A1
20140058324 Salahieh et al. Feb 2014 A1
20140094787 Reynolds Apr 2014 A1
20140187983 Anderson Jul 2014 A1
20140257363 Lippert Sep 2014 A1
20140276109 Gregorich Sep 2014 A1
20140276787 Wang et al. Sep 2014 A1
20140279109 Vasquez et al. Sep 2014 A1
20140309657 Ben-Ami Oct 2014 A1
20140336620 Ayman et al. Nov 2014 A1
20150011834 Ayala et al. Jan 2015 A1
20150011964 Abner et al. Jan 2015 A1
20150057639 Storbeck et al. Feb 2015 A1
20150190614 Bernhard Jul 2015 A1
20150190615 Shaltis Jul 2015 A1
20150216533 Gray et al. Aug 2015 A1
20150238734 Kanazawa Aug 2015 A1
20150290432 Mathews et al. Oct 2015 A1
20150297863 Hannon et al. Oct 2015 A1
20150305710 Stigall et al. Oct 2015 A1
20150306355 Idstrom Oct 2015 A1
20160001048 Koike Jan 2016 A1
20160008585 Tano Jan 2016 A1
20160045101 Nakatate et al. Feb 2016 A1
20160058382 Burkett et al. Mar 2016 A1
20160089128 Weber et al. Mar 2016 A1
20160113793 Nishigishi Apr 2016 A1
20160135827 Elsesser et al. May 2016 A1
20160199620 Pokorney et al. Jul 2016 A1
20160235337 Govari et al. Aug 2016 A1
20160287054 Fujitani Oct 2016 A1
20160310702 Cabiri Oct 2016 A1
20160361520 Braun Dec 2016 A1
20160367788 Jimenez et al. Dec 2016 A1
20160375226 Nabeshima et al. Dec 2016 A1
20170047740 Narla Feb 2017 A1
20170049594 Banas et al. Feb 2017 A1
20170136213 Kauphusman et al. May 2017 A1
20170189643 Christian et al. Jul 2017 A1
20170203076 Groneberg et al. Jul 2017 A1
20170215954 Datta et al. Aug 2017 A1
20170234411 Dewaele et al. Aug 2017 A1
20170281909 Northrop et al. Oct 2017 A1
20180015260 Sano et al. Jan 2018 A1
20180015261 Lippert Jan 2018 A1
20180015262 Lippert et al. Jan 2018 A1
20180015263 Lippert et al. Jan 2018 A1
20180028177 Van et al. Feb 2018 A1
20180071496 Snyder et al. Mar 2018 A1
20180177517 Lippert et al. Jun 2018 A1
20180185619 Batman et al. Jul 2018 A1
20180193603 Falb et al. Jul 2018 A1
20180193607 Lippert et al. Jul 2018 A1
20180207407 Tanigaki Jul 2018 A1
20190008639 Landon et al. Jan 2019 A1
20190105463 Christian et al. Apr 2019 A1
20190175869 Kirt et al. Jun 2019 A1
20190255290 Snyder et al. Aug 2019 A1
20190290883 Lippert et al. Sep 2019 A1
20190358434 Fuller et al. Nov 2019 A1
20200016378 Williams et al. Jan 2020 A1
20200054860 McElhaney et al. Feb 2020 A1
20200094027 Davis Mar 2020 A1
20200121308 Davis et al. Apr 2020 A1
20200222666 Chan et al. Jul 2020 A1
20200222672 Davis et al. Jul 2020 A1
20200330734 Sugita et al. Oct 2020 A1
20200345975 Snyder Nov 2020 A1
20210022748 Lorenzo Jan 2021 A1
20210162184 Lippert et al. Jun 2021 A1
20210178128 Lippert et al. Jun 2021 A1
20210213241 Christian et al. Jul 2021 A1
20210283372 Murphy Sep 2021 A1
20210283380 Lippert et al. Sep 2021 A1
20210307766 Keating et al. Oct 2021 A1
20210346656 Lippert et al. Nov 2021 A1
20220039644 Dayton et al. Feb 2022 A1
20220047845 Niederhauser et al. Feb 2022 A1
20220105312 Davis Apr 2022 A1
20220105318 Davis et al. Apr 2022 A1
20220118225 Snyder et al. Apr 2022 A1
20220176075 Mcdermott et al. Jun 2022 A1
20220218358 Dagan et al. Jul 2022 A1
20220273474 Koop et al. Sep 2022 A1
20220280147 Davis Sep 2022 A1
20220296850 Lippert Sep 2022 A1
20220323166 Tilson et al. Oct 2022 A1
20220378459 Lippert Dec 2022 A1
20230010697 Sharma et al. Jan 2023 A1
20230069698 Hallauer et al. Mar 2023 A1
20230071512 Maggio et al. Mar 2023 A1
20230082226 Lippert et al. Mar 2023 A1
20230285720 Isogai Sep 2023 A1
20230405276 Cabiri Dec 2023 A1
20240123196 Lippert et al. Apr 2024 A1
20240198059 Lippert et al. Jun 2024 A1
20240299710 Davis et al. Sep 2024 A1
Foreign Referenced Citations (145)
Number Date Country
0723040 Aug 2000 AU
733966 May 2001 AU
0774559 Jul 2004 AU
2008229892 Oct 2008 AU
9709363 Jan 2000 BR
9712829 Jan 2000 BR
2255781 Nov 1997 CA
2266685 Mar 1998 CA
2395149 Jun 2001 CA
1225282 Aug 1999 CN
1230914 Oct 1999 CN
1324285 Nov 2001 CN
1422673 Jun 2003 CN
1518428 Aug 2004 CN
1781684 Jun 2006 CN
1897892 Jan 2007 CN
101001660 Jul 2007 CN
101209365 Jul 2008 CN
101304778 Nov 2008 CN
201239164 May 2009 CN
101815553 Aug 2010 CN
102049085 May 2011 CN
102107041 Jun 2011 CN
102548603 Jul 2012 CN
102639303 Aug 2012 CN
102824681 Dec 2012 CN
102847225 Jan 2013 CN
103301553 Sep 2013 CN
103764012 Apr 2014 CN
103860265 Jun 2014 CN
104271035 Jan 2015 CN
104427950 Mar 2015 CN
104602616 May 2015 CN
104602718 May 2015 CN
104759022 Jul 2015 CN
105209102 Dec 2015 CN
105361918 Mar 2016 CN
105545375 May 2016 CN
105582611 May 2016 CN
105682725 Jun 2016 CN
105682729 Jun 2016 CN
105828690 Aug 2016 CN
105979880 Sep 2016 CN
107206216 Sep 2017 CN
109125889 Jan 2019 CN
109715245 May 2019 CN
109789296 May 2019 CN
60036882 Jul 2008 DE
69738235 Jul 2008 DE
0521595 Jan 1993 EP
0921754 Jun 1999 EP
0998323 May 2000 EP
0934141 Nov 2005 EP
1239901 Oct 2007 EP
1844911 Oct 2007 EP
1940498 Jul 2008 EP
2964305 Jan 2016 EP
2414022 Aug 2017 EP
2293660 Mar 2008 ES
2478988 Sep 2011 GB
59-102509 Jun 1984 JP
06-154335 Jun 1994 JP
07-008560 Jan 1995 JP
08-215313 Aug 1996 JP
08-243169 Sep 1996 JP
08-308934 Nov 1996 JP
09-288239 Nov 1997 JP
11-294497 Oct 1999 JP
2000-116787 Apr 2000 JP
2000-126301 May 2000 JP
2000-511094 Aug 2000 JP
2000-343313 Dec 2000 JP
2001-500808 Jan 2001 JP
2002-543896 Dec 2002 JP
2003-011117 Jan 2003 JP
2004-025340 Jan 2004 JP
2004-136121 May 2004 JP
2004-329552 Nov 2004 JP
2004-535233 Nov 2004 JP
2005-514115 May 2005 JP
2005-533594 Nov 2005 JP
2005-534407 Nov 2005 JP
2007-514458 Jun 2007 JP
2007-313638 Dec 2007 JP
2008-178656 Aug 2008 JP
2008-536639 Sep 2008 JP
2010-029736 Feb 2010 JP
2010-503484 Feb 2010 JP
2010-535583 Nov 2010 JP
2010-535588 Nov 2010 JP
2011-206175 Oct 2011 JP
4805208 Nov 2011 JP
4845313 Dec 2011 JP
2012-502743 Feb 2012 JP
2012-522607 Sep 2012 JP
2013-106854 Jun 2013 JP
2013-523282 Jun 2013 JP
2013-176560 Sep 2013 JP
2014-023727 Feb 2014 JP
2015-073861 Apr 2015 JP
2015-181723 Oct 2015 JP
2015-186427 Oct 2015 JP
2016-013269 Jan 2016 JP
2017-169253 Sep 2017 JP
2000-0015896 Mar 2000 KR
10-2000-0036139 Jun 2000 KR
2017570 Apr 2018 NL
91674 Feb 2010 RU
412468 Nov 2000 TW
9406503 Mar 1994 WO
9419039 Sep 1994 WO
9524237 Sep 1995 WO
9743949 Nov 1997 WO
9855173 Dec 1998 WO
9858697 Dec 1998 WO
9904847 Feb 1999 WO
9953824 Oct 1999 WO
2004011076 Feb 2004 WO
2006025931 Mar 2006 WO
2006058234 Jun 2006 WO
2006113863 Oct 2006 WO
2007050718 May 2007 WO
2008034010 Mar 2008 WO
2009020691 Feb 2009 WO
2009020836 Feb 2009 WO
2009020961 Feb 2009 WO
2009020962 Feb 2009 WO
2009143160 Nov 2009 WO
2010077692 Jul 2010 WO
2010115163 Oct 2010 WO
2011123689 Oct 2011 WO
2014005095 Jan 2014 WO
2014066104 May 2014 WO
2014138580 Sep 2014 WO
2016047499 Mar 2016 WO
2016117238 Jul 2016 WO
2016136609 Sep 2016 WO
2016152194 Sep 2016 WO
2016158671 Oct 2016 WO
2017151292 Sep 2017 WO
2018017349 Jan 2018 WO
2018017351 Jan 2018 WO
2018218216 Nov 2018 WO
2020217171 Oct 2020 WO
2022159139 Jul 2022 WO
Non-Patent Literature Citations (121)
Entry
Final Office Action received for U.S. Appl. No. 16/281,046, mailed on May 11, 2021, 18 pages.
International Search Report and Written Opinion for PCT/US2019/021031 mailed on Jun. 18, 2019.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/14656, mailed on Apr. 28, 2021, 8 pages.
Final Office Action received for U.S. Appl. No. 16/742,211, mailed on Mar. 14, 2023, 22 pages.
Final Office Action received for U.S. Appl. No. 16/855,366, mailed on Dec. 8, 2022, 18 pages.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/053647, mailed on Dec. 28, 2021, 9 pages.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/053652, mailed on Dec. 28, 2021, 9 pages.
Non-Final Office Action received for U.S. Appl. No. 17/177,782, mailed on Jan. 23, 2023, 14 pages.
Final Office Action received for U.S. Appl. No. 15/848,878, mailed on Sep. 22, 2021, 12 pages.
Final Office Action received for U.S. Appl. No. 16/616,220, mailed on Oct. 12, 2022, 17 pages.
Final Office Action received for U.S. Appl. No. 17/216,127, mailed on Jun. 13, 2022, 8 pages.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/042753, mailed on Nov. 5, 2021, 14 pages.
Non-Final Office Action received for U.S. Appl. No. 16/616,139, mailed on Oct. 26, 2021, 11 pages.
Non-Final Office Action received for U.S. Appl. No. 16/616,220, mailed on Jun. 3, 2022, 20 pages.
Non-Final Office Action received for U.S. Appl. No. 16/742,211, mailed on Aug. 15, 2022, 20 pages.
Non-Final Office Action received for U.S. Appl. No. 16/855,366, mailed on Jul. 11, 2022, 13 pages.
Non-Final Office Action received for U.S. Appl. No. 16/855,366, mailed on Jun. 23, 2021, 15 pages.
Non-Final Office Action received for U.S. Appl. No. 17/177,782, mailed on Nov. 4, 2022, 7 pages.
Final Office Action received for U.S. Appl. No. 12/753,831, mailed on May 31, 2012.
Final Office Action received for U.S. Appl. No. 12/753,836 mailed on Feb. 17, 2016.
Final Office Action received for U.S. Appl. No. 16/212,425, mailed on Aug. 3, 2020, 14 pages.
Final Office Action received for U.S. Appl. No. 12/753,831, mailed on Aug. 29, 2014.
Final Office Action received for U.S. Appl. No. 12/753,836, mailed on Jan. 9, 2015.
Final Office Action received for U.S. Appl. No. 12/753,836, mailed on May 1, 2012.
Final Office Action received for U.S. Appl. No. 12/753,849, mailed on Jun. 6, 2012.
Final Office Action received for U.S. Appl. No. 12/753,849, mailed on Oct. 9, 2013.
Final Office Action received for U.S. Appl. No. 12/753,855, mailed on Apr. 18, 2012.
Final Office Action received for U.S. Appl. No. 12/753,855, mailed on Jan. 13, 2015.
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Jan. 17, 2014.
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Jul. 18, 2012.
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on May 28, 2015.
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Oct. 19, 2011.
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Oct. 20, 2017.
Final Office Action received for U.S. Appl. No. 12/753,836, mailed on Jul. 14, 2017.
Final Office Action received for U.S. Appl. No. 15/606,607 mailed on Nov. 19, 2019.
Final Office Action received for U.S. Appl. No. 15/848,878, mailed on Aug. 27, 2020, 13 pages.
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Nov. 14, 2018.
Final Office Action received for U.S. Appl. No. 12/753,839 mailed on May 31, 2012.
Final Office Action received for U.S. Appl. No. 14/199,675, mailed on May 18, 2017.
Final Office Action received for U.S. Appl. No. 15/611,328, mailed on Sep. 24, 2019.
Final Office Action received for U.S. Appl. No. 15/611,344, mailed on Nov. 12, 2019.
Final Office Action received for U.S. Appl. No. 15/698,553, mailed on Nov. 27, 2019.
Final Rejection received for U.S. Appl. No. 15/606,607, mailed on Dec. 15, 2020, 24 pages.
International Search Report and Written Opinion for application No. PCT/US17/41299 dated Oct. 2, 2017.
International Search Report and Written Opinion for application No. PCT/US17/41301 dated Oct. 2, 2017.
International Search Report and Written Opinion for application No. PCT/US17/41305 dated Oct. 2, 2017.
International Search Report and Written Opinion for Application PCT/US2017/050602 mailed on Nov. 7, 2017.
International Search Report and Written Opinion for application PCT/US2017/050802 dated Nov. 7, 2017.
International Search Report and Written Opinion for application PCT/US2017/050802 mailed on Nov. 7, 2017.
International Search Report and Written Opinion for PCT/US2009/067217 dated Dec. 16, 2010.
International Search Report and Written Opinion for PCT/US2010/029867 dated Jun. 1, 2010.
International Search Report and Written Opinion for PCT/US2014/021742 dated Aug. 27, 2014.
International Search Report and Written Opinion for PCT/US2017/041299 mailed on Oct. 2, 2017.
International Search Report and Written Opinion for PCT/US2017/041301 mailed on Oct. 2, 2017.
International Search Report and Written Opinion for PCT/US2017/068056 mailed on Feb. 26, 2018.
International Search Report and Written Opinion for PCT/US2018/034723 dated Sep. 5, 2018.
International Search Report and Written Opinion for PCT/US2018/034756 mailed on Aug. 14, 2018.
International Search Report and Written Opinion for PCT/US2019/019046, mailed on May 17, 2019.
International Search Report and Written Opinion issued in PCT/US2018/034723 mailed Sep. 5, 2018.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2020/030589, mailed on Jul. 17, 2020, 7 pages.
International Search Report and Written Opinion, PCT App. No. PCT/US2020/013754, mailed on Jun. 9, 2020, 11 pages.
Non-Final Office Action received for U.S. Appl. No. 15/606,607, mailed on Jun. 10, 2020, 26 pages.
Non-Final Office Action received for U.S. Appl. No. 15/611,328, mailed on Jun. 29, 2020, 13 pages.
Non-Final Office Action received for U.S. Appl. No. 15/917,255, mailed on Aug. 17, 2020, 12 pages.
Non-Final Office Action received for U.S. Appl. No. 16/281,046, mailed on Oct. 29, 2020, 18 pages.
Office Action received for U.S. Appl. No. 12/633,727, mailed on Oct. 16, 2012.
Non-Final Office Action received for U.S. Appl. No. 15/848,878, mailed on Jun. 3, 2021, 13 pages.
Office Action received for European Patent Application No. 19710207.2, mailed on Dec. 4, 2023, 4 pages.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US22/42514, mailed on Dec. 28, 2022, 11 pages.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US22/42517, mailed on Feb. 7, 2023, 11 pages.
Supplementary European Search Report received for EP Patent Application No. 21744674.9, mailed on Feb. 7, 2024, 9 pages.
Office Action received for U.S. Appl. No. 12/753,831, mailed on Feb. 1, 2012.
Office Action received for U.S. Appl. No. 12/753,831, mailed on Mar. 21, 2014.
Office Action received for U.S. Appl. No. 12/753,836, mailed on Dec. 9, 2011.
Office Action received for U.S. Appl. No. 12/753,836, mailed on Dec. 23, 2016.
Office Action received for U.S. Appl. No. 12/753,836, mailed on Jul. 31, 2014.
Office Action received for U.S. Appl. No. 12/753,836, mailed on Jun. 26, 2015.
Office Action received for U.S. Appl. No. 12/753,839, mailed on May 5, 2014.
Office Action received for U.S. Appl. No. 12/753,842, mailed on Jan. 29, 2014.
Office Action received for U.S. Appl. No. 12/753,849, mailed on Jan. 3, 2013.
Office Action received for U.S. Appl. No. 12/753,849, mailed on May 10, 2011.
Office Action received for U.S. Appl. No. 12/753,849, mailed on May 27, 2014.
Office Action received for U.S. Appl. No. 12/753,849, mailed on Oct. 18, 2011.
Office Action received for U.S. Appl. No. 12/753,855, mailed on Feb. 28, 2014.
Office Action received for U.S. Appl. No. 12/753,855, mailed on May 21, 2015.
Office Action received for U.S. Appl. No. 12/753,855, mailed on Sep. 15, 2011.
Office Action received for U.S. Appl. No. 12/753,858, mailed on Dec. 30, 2015.
Office Action received for U.S. Appl. No. 12/753,858, mailed on Feb. 3, 2012.
Office Action received for U.S. Appl. No. 12/753,858, mailed on Mar. 13, 2018.
Office Action received for U.S. Appl. No. 12/753,858, mailed on Mar. 27, 2017.
Office Action received for U.S. Appl. No. 12/753,858, mailed on Mar. 29, 2013.
Office Action received for U.S. Appl. No. 12/753,858, mailed on May 10, 2011.
Office Action received for U.S. Appl. No. 12/753,858, mailed on Oct. 24, 2016.
Office Action received for U.S. Appl. No. 12/753,858, mailed on Sep. 4, 2014.
Office Action received for U.S. Appl. No. 13/901,375, mailed on Aug. 1, 2016.
Office Action received for U.S. Appl. No. 13/901,375, mailed on Dec. 10, 2015.
Office Action received for U.S. Appl. No. 15/606,607 mailed on May 14, 2019.
Office Action received for U.S. Appl. No. 15/611,344, mailed on May 21, 2020.
Office Action received for U.S. Appl. No. 15/698,553, mailed on Nov. 27, 2019.
Office Action received for U.S. Appl. No. 15/848,878, mailed on Feb. 5, 2020.
Office Action received for U.S. Appl. No. 16/212,425, mailed on Mar. 16, 2020.
Office Action received for U.S. Appl. No. 12/753,855 mailed on May 5, 2016.
Office Action received for U.S. Appl. No. 14/199,675, mailed on Nov. 3, 2016.
Office Action received for U.S. Appl. No. 15/465,399, mailed on Apr. 23, 2018.
Office Action received for U.S. Appl. No. 15/611,328, mailed on Mar. 27, 2019.
Office Action received for U.S. Appl. No. 15/611,344, mailed on Mar. 26, 2019.
Penumbra Augments Vascular Franchise with Latest Indigo System Launch and Expands Medical/Scientific Leadership, Jul. 14, 2020, https://investors.penumbrainc.com/investors-relations/press-releases/press-release-details/2020/Penumbra-Augments-Vascular-Franchise-with-Latest-Indigo-System-Launch-and-Expands-MedicalScientific-Leadership/default.aspx.
U.S. Appl. No. 12/753,839, filed Feb. 7, 2012, Office Action.
U.S. Appl. No. 12/753,839, filed May 31, 2012, Final Office Action.
U.S. Appl. No. 12/753,842, filed Aug. 1, 2012, Office Action.
U.S. Appl. No. 12/753,842, filed Jan. 9, 2013, Final Office Action.
U.S. Appl. No. 12/753,842, filed Sep. 4, 2014, Final Office Action.
U.S. Appl. No. 12/753,858, filed May 28, 2015, Final Office Action.
Final Office Action received for U.S. Appl. No. 16/855,366, mailed on Jun. 20, 2024, 17 pages.
Final Office Action received for U.S. Appl. No. 17/836,863, mailed on Jun. 25, 2024, 6 pages.
Non-Final Office Action received for U.S. Appl. No. 17/382,271, mailed on May 14, 2024, 22 pages.
Non-Final Office Action received for U.S. Appl. No. 17/493,265, mailed on Jun. 11, 2024, 19 pages.
European Search Report received for EP Patent Application No. 21878402, mailed on Aug. 14, 2024, 13 pages.
Final Office Action received for U.S. Appl. No. 17/382,271, mailed on Sep. 16, 2024, 9 pages.
Non-Final Office Action received for U.S. Appl. No. 17/752,600, mailed on Sep. 10, 2024, 11 pages.
Requirement for Restriction/Election received for U.S. Appl. No. 17/493,281, mailed on Oct. 9, 2024, 13 pages.
Related Publications (1)
Number Date Country
20210228845 A1 Jul 2021 US
Provisional Applications (1)
Number Date Country
62965005 Jan 2020 US